Getinge AB stock (SE0000202624): Surgical booms market growth highlights medtech positioning

Getinge AB features prominently in a recent surgical booms market report projecting strong sector expansion, underscoring its role in hospital infrastructure amid rising demand for advanced medical equipment.

Getinge AB, a key player in the medical technology sector, is highlighted in a market research report on surgical booms released in early 2026. The report positions Getinge alongside competitors like Stryker Corporation and Siemens Healthineers in a market expected to boom due to increasing needs in operating rooms and emergency departments, according to openPR as of May 2026. This development reflects broader trends in healthcare infrastructure upgrades relevant to US investors tracking global medtech exposure.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Getinge AB
• Sector/industry: Medical devices and healthcare equipment
• Headquarters/country: Sweden
• Core markets: Europe, North America, Asia
• Key revenue drivers: Acute care equipment, surgical systems, life support
• Home exchange/listing venue: Nasdaq Stockholm (GETI B)
• Trading currency: SEK

Getinge AB: core business model

Getinge AB develops and supplies medical devices for operating rooms, intensive care units, and sterilization processes worldwide. The company focuses on solutions that enhance patient safety and workflow efficiency in hospitals. Its product portfolio includes surgical tables, lights, booms, and ventilation systems, serving acute care settings globally, including significant exposure to the US healthcare market through partnerships and direct sales.

With a presence in over 40 countries, Getinge emphasizes innovation in medtech to address aging populations and rising surgical volumes. The business model relies on recurring revenue from service contracts alongside equipment sales, providing stability amid market fluctuations.

Main revenue and product drivers for Getinge AB

Surgical infrastructure products, such as booms and integration systems, represent a core revenue stream, as noted in recent market analyses. These systems support advanced operating theaters, with demand driven by hospital expansions and tech upgrades. Getinge's extended portfolio includes patient handling, disinfection, and monitoring solutions, contributing to diversified income across acute care segments.

North America accounts for a substantial portion of sales, making Getinge relevant for US investors interested in medtech firms with transatlantic operations. Growth in emergency department equipment further bolsters its position in high-volume healthcare environments.

Industry trends and competitive position

The surgical booms market is expanding due to modernization of operating rooms and integration of digital technologies. Getinge competes with Stryker, Hill-Rom, and Trumpf Medical, leveraging its Maquet brand for specialized equipment. This positioning supports steady demand in procedural growth areas like minimally invasive surgery.

US hospitals, facing infrastructure investments, drive relevance for Getinge shares among investors eyeing global medtech plays with strong European roots and American market penetration.

Why Getinge AB matters for US investors

Getinge AB offers US investors exposure to the resilient medtech sector without direct US listing, via OTC trading or international portfolios. Its products equip American hospitals, tying performance to US healthcare spending trends and elective procedure recoveries post-pandemic.

Conclusion

Getinge AB continues to play a vital role in medical infrastructure, as evidenced by its inclusion in expanding market reports. Investors monitor sector dynamics, competitive pressures, and global healthcare demands influencing the company's trajectory. The stock remains a point of interest for those tracking medtech developments with cross-border implications.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.